Photo: Mark Hanson at Mark Joseph Studios
A new discovery from MCB Professor of the Graduate School Terry Machen and a team from the University of Saskatchewan may lead to new cystic fibrosis drugs that are more effective and better-tolerated by those suffering from the disease.